Phase 1/1b Multicenter Open-Label Study of RMC 9805 in Participants With Advanced KRASG12D-Mutant Solid Tumors
Brief description of study
Phase 1/1b, Multicenter, Open-Label, Study of RMC 9805 in Participants With Advanced KRASG12D-Mutant Solid Tumors
Clinical Study Identifier: s24-00119
ClinicalTrials.gov Identifier: NCT06040541
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
